There is a word I didn't use, but I assumed people would infer because with situations like this, you need a lot of them. Contingencies. Contingency planning is a huge part of what is necessary to adequately adapt to new, unknown and changing conditions, such as this one. Most contingency plans are just discussions and paperwork and don't go beyond that. New info breeds new streams of contingencies. But people in authority (and us in the back of of our minds, so we aren't taken off guard), absolutely need to be having them now, and what I am advocating for, not the alternative path of doing nothing while waiting for data, because you can't put plans into place after the fact and have them have an impact. We need contingencies if it's valid. We need contingencies if it's not. A two-prong approach. Pausing at the fork in the road, and reviewing your defenses. Keeping an eye on how you can get from one path to another. Not just keep running down, the side you've been on at the same speed. Mitigations are not much different than putting on safety gear when entering a construction site, slowing down when approaching an accident scene. They're the things you do... things we usually do, when info is scant or contradictory. A flip here, is not doing that much outside of expressing some caution when caution is warranted (still the case that no one has been here, with this virus before), although people are acting as if it's the worst thing that can happen. Boosters have been primarily considered in the context of the high risk cohort (age and immunocompromised). That was the case long before the Israel study, it's the case after the Israel study. Talking about them is not a change of strategy or policy. They were always on this table. This is a potential bullet point as to why that initial assumption continues to be a smart assumption and still on the table.
I had to use a lot of qualifying language to try to demonstrate that what I am advocating for is not a radical change of strategy. It's a willingness to think and discuss the possibility, that this is yet another situation where things did not turn out the way that people wanted. The things we were told from the beginning might be necessary, still might be, even this far in the process. That vaccinated people still have a role in mild infections and transmissions, and we didn't just tap out of the game completely, like we thought. But at the end of the day. "Wait and see" has no chance of changing what happens over the next few weeks or months. Either we are committed to limiting community transmission, or we end up letting it continue. "Wait and see" is just a nicer way of saying, "We're letting it rip."
Also, I disagree with the framing of Israel data as an outlier, because they hold an important role in all of this. They were the first to get their population to high levels of vaccinations. Their data, will frequently represent a fresh page, a new chapter in how this unfolds. They are the canary in the coal mine. And this is really recent data! That type of information always holds the potential of being different. We need information regarding the possibility of waning protection. This tweet tells us where to look to find that info
Pfizer is not the least effective vaccine, but the other elements are present in the Israel data. UK has a different set of circumstances, in part due to their different strategies of getting shots in arms, but also because they are just not as far along the path as Israel is. The Israel data that revealed the lower levels is specifically in the June and July data, outside of what could possibly be captured in the UK data which ended in May. The US is even farther behind on the path, and we have insufficient data by choice. "Lets just put this, maybe first of this kind of info over there for later..." instead of working with it as best we can at the moment, is not going to get us where we want to be. We're going to see things in old/immunocompromised people, that may or may not have implications for the general public. But we can't ignore the implications for that cohort because it might freak everyone else out.